The role of striatal glutamate receptors in models of Parkinson's disease
✍ Scribed by K. Ossowska; E. Lorenc-Koci; J. Konieczny; S. Wolfarth
- Publisher
- Springer
- Year
- 1998
- Tongue
- English
- Weight
- 362 KB
- Volume
- 14
- Category
- Article
- ISSN
- 0939-4451
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Enhanced delta opioid receptor transmission may represent an endogenous compensatory mechanism in parkinsonism to reduce the activity of the indirect striatopallidal pathway following dopamine depletion. Furthermore, increased delta opioid receptor transmission may be causative in the production of
Disruption to different components of the prefrontal cortex, basal ganglia, and hippocampal circuits leads to various psychiatric and neurological disorders including Parkinson's disease (PD) and schizophrenia. Medications used to treat these disorders (such as levodopa, dopamine agonists, antipsych
Sperlágh et al.: The double-faced role of P2X 7 receptors in toxin-induced animal models of Parkinson's disease. BMC Pharmacology 2011 11(Suppl 2):A56.
## Abstract The loss of dopaminergic neurons in the substantia nigra provokes a plasticity of corticostriatal synapses in Parkinson's disease (PD). The corticostriatal pathway nevertheless makes synapses with neurons bearing D1 dopamine receptors (D1R) and/or D2 dopamine receptors. At the ultrastru